Evidence map›Paper›PMID 35325093›Full record

ArticleEuropean journal of public health2022

Impact of the COVID-19 pandemic on contact tracing of patients with pulmonary tuberculosis.

Pere Godoy, Ignasi Parrón, Irene Barrabeig, Joan A Caylà, Laura Clotet, Núria Follia, Monica Carol, Angels Orcau, Miquel Alsedà, Gloria Ferrús and 5 more

Open access · goldAbstract read
In one paragraph

Article in European journal of public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Lived experiences of tuberculosis patients accessing treatment during COVID-19 in Zimbabwe.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2026
    Article
  3. Impact of the COVID-19 pandemic on tuberculosis program performance in Alberta, Canada: a population-based evaluation.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Pere GodoyAgència de Salut Pública Catalunya, Barcelona, Spain.ORCID 0000-0002-2896-7286
Ignasi ParrónAgència de Salut Pública Catalunya, Barcelona, Spain.
Irene BarrabeigAgència de Salut Pública Catalunya, Barcelona, Spain.
Joan A CaylàFoundation of the Tuberculosis Research Unit of Barcelona, Barcelona, Spain.
Laura ClotetAgència de Salut Pública Catalunya, Barcelona, Spain.
Núria FolliaAgència de Salut Pública Catalunya, Barcelona, Spain.
Monica CarolAgència de Salut Pública Catalunya, Barcelona, Spain.
Angels OrcauAgència de Salut Pública de Barcelona, Barcelona, Spain.
Miquel AlsedàAgència de Salut Pública Catalunya, Barcelona, Spain.
Gloria FerrúsAgència de Salut Pública Catalunya, Barcelona, Spain.
Pere PlansAgència de Salut Pública Catalunya, Barcelona, Spain.
Mireia JaneAgència de Salut Pública Catalunya, Barcelona, Spain.
Joan-Pau MilletConsorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Angela DomínguezConsorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Transmission of Tuberculosis in Catalonia (Spain) Working Group
Agència de Salut Pública de Catalunya · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic could have negative effects on tuberculosis (TB) control. The objective was to assess the impact of the pandemic in contact tracing, TB and latent tuberculosis infection (LTBI) in contacts of patients with pulmonary TB in Catalonia (Spain).

methodsContact tracing was carried out in cases of pulmonary TB detected during 14 months in the pre-pandemic period (1 January 2019 to 28 February 2020) and 14 months in the pandemic period (1 March 2020 to 30 April 2021). Contacts received the tuberculin skin test and/or interferon gamma release assay and it was determined whether they had TB or LTBI. Variables associated with TB or LTBI in contacts (study period and sociodemographic variables) were analyzed using adjusted odds ratio (aOR) and the 95% confidence intervals (95% CI).

resultsThe pre-pandemic and pandemic periods showed, respectively: 503 and 255 pulmonary TB reported cases (reduction of 50.7%); and 4676 and 1687 contacts studied (reduction of 36.1%). In these periods, the proportion of TB cases among the contacts was 1.9% (84/4307) and 2.2% (30/1381) (P = 0.608); and the proportion of LTBI was 25.3% (1090/4307) and 29.2% (403/1381) (P < 0.001). The pandemic period was associated to higher LTBI proportion (aOR = 1.3; 95% CI 1.1-1.5), taking into account the effect on LTBI of the other variables studied as sex, age, household contact and migrant status.

conclusionsCOVID-19 is affecting TB control due to less exhaustive TB and LTBI case detection. An increase in LTBI was observed during the pandemic period. Efforts should be made to improve detection of TB and LTBI among contacts of TB cases.

Indexed as

COVID-19Latent TuberculosisTuberculosisTuberculosis, PulmonaryContact TracingHumansPandemicsTuberculin Test

Identifiers

PMID35325093
PMCPMC8992232
OpenAlexW4220820177

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.